Skip to content

Effect of Smart Phone App-based Human Coaching Program in Gastrectomized Patients

A Study Evaluating Effect of Smart Phone App-based Human Coaching Program on QOL in Patients Who Underwent Gastrectomy for Stage I Gastric Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04394585
Enrollment
180
Registered
2020-05-19
Start date
2020-05-11
Completion date
2023-12-31
Last updated
2025-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage I Gastric Cancer

Keywords

gastric cancer, quality of life, smart phone app, human coaching program

Brief summary

This study is a single center, prospective, randomized controlled study. The aim of this study is to evaluate the effect of smart phone app-based human coaching program on QOL in patients who underwent gastrectomy for stage I gastric cancer. The hypothesis of this study is the patients who used smart phone app-based human coaching program for three months after surgery will have better QOL than patients who did not use it. The QOL will be assessed using EORTC QLQ C30 and STO22 at 3 months postoperatively. The secondary endpoints are QOL at 6 months postoperatively, 12 months postoperative, food intake, body composition, and nutritional indicators from blood test.

Detailed description

\< Patient enrollment\> * 90 patients in each group, a total of 180 patients * 1:1 Randomization using permutated mixed block randomization * stratified by surgical extent (distal gastrectomy vs. total gastrectomy) * using nQuery program and web-based management system * Before discharge, patients are informed how to use the smart phone app and registered to the app. * Patients use the app after discharge until 3 months postoperatively.

Interventions

BEHAVIORALsmart phone app based human coaching program

1. experimental arm * 1:1 coaching using smart phone app * Patients are provided several articles about postoperative care (symptom management, diet, and exercise) in the app. * Patients are encouraged to report their diet diaries and exercise everyday by the coach. * Patients can ask to the coach using the app and the coach answer when they check them. 2. Comparator arm - Patient have consulting with clinical nutritionist at 1 month and 3 months postoperatively.

Sponsors

National Cancer Center, Korea
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient aged 19 or more * patient diagnosed as stage I in preoperative examination * planned distal gastrectomy or total gastrectomy * patient who can use smart phone app or whose family can help the * patient to use the smart phone app

Exclusion criteria

* pregnant * disabled to communication * patient who cannot use smart phone app

Design outcomes

Primary

MeasureTime frameDescription
Eating restriction score (XEatR) at 1 month postoperatively1 month postoperativelyEating resection scale is calculated according to the following equation. a. Add questionnaire items 41,42, 43 and 46 and divide this sum by the number of items (4): EatR = (Q41+Q42+Q43+Q46)/4 b. Carry out a linear transformation to convert to a 1-100 scale: XEatR = (EatR-1)\*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life.
Eating restriction score (XEatR) at 3 months postoperatively3 months postoperativelyEating resection scale is calcuated according to the following equation. 1. Add questionnaire items 41,42, 43 and 46 and divide this sum by the number of items (4): EatR = (Q41+Q42+Q43+Q46)/4 2. Carry out a linear transformation to convert to a 1-100 scale: XEatR = (EatR-1)\*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life.

Secondary

MeasureTime frameDescription
food intakedischarge day: up to 3 weeks postoperatively,1 month postoperativelydifference of food amount between discharge day and postoperative 1 month
Body weight3 months postoperativelypatient's weight in kilograms
serum albumin3 months postoperativelyg/dL
Eating restriction score (XEatR) at 6 months postoperatively6 months postoperativelyEating resection scale is calcuated according to the following equation. 1. Add questionnaire items 41,42, 43 and 46 and divide this sum by the number of items (4): EatR = (Q41+Q42+Q43+Q46)/4 2. Carry out a linear transformation to convert to a 1-100 scale: XEatR = (EatR-1)\*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life.
serum cholesterol3 months postoperativelyg/dL
seum hemoglobin3 months postoperativelyg/dL
serum protein3 months postoperativelyg/dL
Eating restriction score (XEatR) at 12 months postoperatively12 months postoperativelyEating resection scale is calcuated according to the following equation. 1. Add questionnaire items 41,42, 43 and 46 and divide this sum by the number of items (4): EatR = (Q41+Q42+Q43+Q46)/4 2. Carry out a linear transformation to convert to a 1-100 scale: XEatR = (EatR-1)\*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026